logo

Renewal Of Licensing Fee For The Transgenic Mouse Strain, B-Hil2Ra

Presolicitation · Maryland

Source: SAM.gov

Tender
Presolicitation

The MIB is conducting pre-clinical research on photoimmunotherapy (PIT), a targeted treatment approach that uses light activation to destroy specific cells. One area of this research focuses on IL2RA, a protein expressed on regulatory T cells (Tregs). These cells can reduce the immune system’s ability to respond effectively to cancer. The objective of this work is to selectively eliminate IL2RA-ex

Status
Prospective
Sector
Commercial, Residential
Location
Maryland, United States of America
Updated
3 Nov 2026
Source
SAM.gov

ConstructChat

Ask ConstructChat about Renewal Of Licensing Fee For The Transgenic Mouse Strain, B-Hil2Ra

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Renewal Of Licensing Fee For The Transgenic Mouse Strain, B-Hil2Ra” is a tender record in Taiyo, linked to the Commercial sector. It is issued for works, goods, or services related to Maryland, United States of America.

Participants

Not available for this record.

Status

Original status

presolicitation

Taiyo status

Prospective

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

The MIB is conducting pre-clinical research on photoimmunotherapy (PIT), a targeted treatment approach that uses light activation to destroy specific cells. One area of this research focuses on IL2RA, a protein expressed on regulatory T cells (Tregs). These cells can reduce the immune system’s ability to respond effectively to cancer. The objective of this work is to selectively eliminate IL2RA-expressing Tregs in order to improve anti-cancer immune responses. To support this research, MIB uses a transgenic mouse strain known as B-hIL2RA, which expresses the human form of IL2RA rather than the mouse form. Use of this model is essential because it enables evaluation of the same treatment materials, including antibodies, that are intended for future human application. As a result, this mouse strain has proven invaluable in the MIB’s ongoing research program. The MIB is requesting to renew a licensing fee for transgenic mice, B-hIL2RA. B-hIL2RA transgenic mice.

Original sector

Information

Location

Country

United States of America (USA)

State

Maryland

Source

Source

SAM.gov

URL

More Details

Record type

Tender

Sector

Commercial, Residential

Article published date

2026-05-29

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender